Plunkett Research Online: Epizyme Inc

EPIZYME INC (EPZM:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Epizyme, Inc. is a biopharmaceutical company offering treatment for people with cancer and other serious diseases via discovery, development and commercialization of novel epigenetic medicines. In early-2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval of TAZVERIK (taze.....



Epizyme Inc
Ticker: EPZM
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-229-5872
Fax:
Address: 400 Technology Square
4th Floor
Cambridge, MA 02139 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Biopharmaceuticals
ContactsDescription

Robert BazemoreCEO/President/Director
Matthew RosCFO/Other Executive Officer
See More
Epizyme, Inc. is a biopharmaceutical company offering treatment for people with cancer and other serious diseases via discovery, development and commercialization of novel epigenetic medicines. In early-2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval of TAZVERIK (taze.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201920182017201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
TAZVERIK
Tazemetostat
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: